OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
April 17, 2015
Rentschler Biotechnologie expands European manufacturing capabilities with GE Healthcare Life Sciences bioprocess technologies.
April 16, 2015
Recipharm makes a strategic investment in Synthonics and partners in development of novel compounds.
April 15, 2015
Pfizer announces that its Phase III trial for Ibrance met its primary endpoint and was ended early due to efficacy based on an assessment by an independent Data Monitoring Committee.
April 08, 2015
Cornell Stamoran, Catalent Pharma Solutions vice-president, is elected to the board of trustees of the Pharma & Biopharma Outsourcing Association.
April 02, 2015
Big service providers get bigger faster thanks to Big Pharma.
March 30, 2015
Rentschler Biotechnologie launches 2000-L single-use bioreactor and announces additional expansion.
Xcellience receives approval to handle both analytical and manufacturing of DEA Scheduled products.
As an affiliate member, TraceLink brings serialization expertise to the Pharma & Biopharma Outsourcing Association.
March 04, 2015
Patheon cites expanded API services with acquisition of IRIX Pharmaceuticals.
March 03, 2015
Steve Nole joins Grand River Aseptic Manufacturing as director of manufacturing.